Surge in Antibiotic Resistance is Turning Routine Surgery into a High-Stakes Procedure

NEW DELHI — Surgeons and infectious-disease experts are issuing an urgent warning: rising antimicrobial resistance (AMR) is already making routine surgical care riskier, jeopardizing outcomes for common operations and complicated procedures alike. While the crisis spans the globe, the problem is particularly acute in South Asia and other regions where resistant infections have become alarmingly common. Hospitals are reporting an influx of postoperative infections that simply do not respond to standard antibiotics. The trend has prompted immediate calls from global health leaders for stronger hospital stewardship, better rapid diagnostics, and stricter infection control to protect patients and preserve modern surgical practice.

The Fraying Safety Net of Modern Surgery

For nearly a century, antibiotics have served as the invisible safety net of modern medicine. Before a surgeon makes an incision for a routine knee replacement, an appendectomy, or a caesarean section, the patient is almost always given a prophylactic (preventative) dose of antibiotics. This single, preemptive step lowers the risk of a surgical site infection (SSI) substantially.

However, recent clinical and surveillance reports show a rapid increase in bacteria that no longer respond to first-line—and even last-resort—antibiotics. This shift is quietly undermining the very prophylaxis and treatment strategies that surgeons rely on daily. Imagine undergoing a standard joint replacement where the preventative antibiotic fails. The resulting deep-joint infection can require multiple follow-up surgeries, prolonged hospitalizations, or joint fusion.

Data from the World Health Organization’s (WHO) Global Antimicrobial Resistance Surveillance System (GLASS) indicate that in many regions, one in six bacterial infections is now resistant to standard treatments. Resistance is rising fastest among Gram-negative organisms, such as Escherichia coli (E. coli) and Klebsiella pneumoniae. These pathogens are common culprits behind urinary tract infections, bloodstream infections, and surgical complications.

Regional studies and multi-centre hospital audits point to an especially high burden in South Asia. In this region, high community carriage rates of multidrug-resistant organisms mean patients often enter the operating theater already colonized with stubborn bacteria, drastically increasing their vulnerability to postoperative sepsis.

Perspectives from the Frontlines

Medical professionals observing the crisis highlight that the window for action is narrowing.

“Without effective antibiotics for prophylaxis and treatment, even minor procedures can become life-threatening,” explains Dr. Arati Mukherjee, an infectious-disease specialist who has monitored AMR trends in tertiary care hospitals for over a decade. “We cannot rely solely on the hope of new drugs. Preserving antibiotic efficacy depends on coordinated, systems-level actions.”

Surgeons warn that rising resistance is forcing a shift in perioperative practice. Rather than relying on standard, broad-spectrum guidelines, teams must increasingly tailor antibiotic regimens to individual patients based on culture results. In areas where resistant organisms are highly prevalent within facilities, some surgical teams are finding it necessary to reevaluate the risk-benefit balances of elective high-risk procedures.

Why the Crisis is Accelerating

The drivers of the AMR crisis are multifaceted, cutting across human medicine, agriculture, and systemic infrastructure:

• Misuse and Overuse: The persistent overuse of antibiotics in both human healthcare and agriculture remains the primary driver. In many developing economies, antibiotics can still be purchased over the counter without a prescription, leading to self-medication for viral illnesses like the common cold.

• The Diagnostic Gap: A lack of access to rapid diagnostics means doctors often have to guess which bacteria is causing an infection. As a safety measure, they frequently prescribe broad-spectrum drugs, which inadvertently accelerates the selection and spread of resistant strains.

• The Drug Pipeline Problem: Developing new antibiotics is financially risky for pharmaceutical companies because new drugs are intentionally held in reserve to prevent resistance. A recent WHO pipeline report highlighted a critical shortage of innovative antibiotics and diagnostics in development. Clinical practice must stretch dwindling therapeutic options while preventive measures are scaled up.

Public Health and Economic Strains

If antibiotic efficacy continues to decline, the public health consequences will be severe. Modeling studies estimate that hundreds of thousands of additional postoperative infections and related deaths could occur annually if standard prophylaxes lose their utility. Patients face extended intensive care unit (ICU) stays, long-term disability, and heightened mortality risks.

For healthcare systems, the financial toll is unsustainable. Managing a resistant infection requires longer admissions, expensive “reserve” or second-line drugs (which often carry harsher side effects), and isolated hospital beds to prevent outbreaks. These requirements place an immense burden on already stretched hospital resources, particularly in low- and middle-income settings.

Because the drug pipeline is slow, experts emphasize that the most immediate gains will come from non-pharmaceutical interventions. This includes strengthening infection prevention and control (IPC) practices—such as rigid hand hygiene, sterile surgical techniques, and meticulous device care—along alongside widening access to clean water, sanitation, and routine vaccines.

Room for Nuance: Facing Data Gaps and Finding Hope

While the trajectory of AMR is concerning, public health experts emphasize that a worst-case scenario is not inevitable.

First, global surveillance remains incomplete. Many official estimates rely on centralized laboratory networks, which frequently underrepresent rural or resource-limited settings. Consequently, the local burden in certain areas may be higher than official datasets indicate, highlighting a critical need for better data collection rather than panic.

Second, trends can be slowed. Evidence shows that when hospitals implement strict antimicrobial stewardship programs—restricting the use of reserve antibiotics and utilizing rapid diagnostics to target specific pathogens—resistance rates can stabilize or even partially reverse. Coordinated public health policies and tighter regulations on over-the-counter antibiotic sales have yielded positive results in several nations.

Finally, surgical outcomes rely on multiple variables. Not every complication is driven by antibiotic failure. Surgical technique, operating room ventilation, patient comorbidities (like diabetes or smoking), and general perioperative care remain vital determinants of patient health. Optimizing these factors provides an immediate layer of protection even as medical science battles chemical resistance.

Practical Takeaways

For Patients

• Ask Questions: Before scheduling a procedure, ask your surgical team about their specific infection-prevention bundles.

• Disclose History: Inform your doctor about any recent antibiotic use (within the past six months) or recent stays in other healthcare facilities.

• Follow Instructions: If you are prescribed antibiotics after surgery, take them exactly as directed. Never demand antibiotics for viral symptoms.

For Clinicians and Hospitals

• Prioritize Stewardship: Audit antibiotic use regularly and restrict “last-resort” drugs to confirmed cases.

• Invest in Diagnostics: Utilize rapid bacterial cultures and PCR testing wherever possible to replace empirical broad-spectrum prescribing.

• Enforce Strict IPC: Maintain rigorous adherence to basic infection-prevention protocols across all wards, not just the operating room.

References & Sources

• Business Standard: “Antibiotic resistance emerging as major threat to surgical care, experts say”, published July 12, 2026. Coverage of multi-centre hospital audits and regional surgical site infection data.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.